Detalhe da pesquisa
1.
The Use of Wearable Devices in Oncology Patients: A Systematic Review.
Oncologist
; 29(4): e419-e430, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971410
2.
Matching-adjusted indirect comparison of amivantamab vs mobocertinib in platinum-pretreated EGFR Exon 20 insertion-mutated non-small-cell lung cancer.
Future Oncol
; 20(8): 447-458, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882460
3.
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
Support Care Cancer
; 31(7): 404, 2023 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341839
4.
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges.
Br J Cancer
; 127(4): 592-602, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347327
5.
Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.
Oncologist
; 27(8): 675-684, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552444
6.
Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer.
J Natl Compr Canc Netw
; 20(4): 361-370.e3, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34492632
7.
The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data.
Qual Life Res
; 30(2): 445-454, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851601
8.
The financial impact of cancer care on renal cancer patients.
Can J Urol
; 28(4): 10762-10767, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378512
9.
Value assessment of oncology drugs using a weighted criterion-based approach.
Cancer
; 126(7): 1530-1540, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860138
10.
Adherence to human epidermal growth factor receptor-2 testing and adjuvant trastuzumab treatment guidelines in Ontario.
J Oncol Pharm Pract
; 26(2): 379-385, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31156051
11.
Anaplastic lymphoma kinase 5A4 immunohistochemistry as a diagnostic assay in lung cancer: A Canadian reference testing center's results in population-based reflex testing.
Cancer
; 125(22): 4043-4051, 2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390053
12.
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
Oncologist
; 24(7): e510-e517, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478189
13.
The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis.
Oncologist
; 24(7): e501-e509, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952820
14.
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Mol Carcinog
; 58(11): 1960-1973, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355511
15.
Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial.
BMC Cancer
; 19(1): 552, 2019 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31174497
16.
Oral targeted therapy for the treatment of non-small cell lung carcinoma.
CMAJ
; 196(16): E558-E561, 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684283
17.
The Role of Angiogenesis Inhibitors in the Era of Immune Checkpoint Inhibitors and Targeted Therapy in Metastatic Non-Small Cell Lung Cancer.
Curr Treat Options Oncol
; 20(3): 21, 2019 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778772
18.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129443
19.
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Lancet Oncol
; 18(11): 1523-1531, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29055736
20.
Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.
Oncologist
; 22(1): 70-80, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27534573